Effect of DLK1 on tumorigenesis in CD34(+)CD38(−) bone marrow cells in myelodysplastic syndromes

Por ZHANG, WEI, SHAO, ZONGHONG, FU, RONG, WANG, HUAQUAN, LI, LIJUAN, YUE, LANZHU
Publicado em 2013

Mesenchymal Cell Reprogramming in Experimental MPL(W515L) Mouse Model of Myelofibrosis

Por Han, Ying, Yue, Lanzhu, Wei, Max, Ren, Xiubao, Shao, Zonghong, Zhang, Ling, Levine, Ross L., Epling-Burnette, Pearlie K.
Publicado no PLoS One (2017)

Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Por Li, Jing, Yue, Lanzhu, Wang, Huaquan, Liu, Chunyan, Liu, Hui, Tao, Jinglian, Qi, Weiwei, Wang, Yihao, Zhang, Wei, Fu, Rong, Shao, Zonghong
Publicado no J Immunol Res (2016)

Efficacy of ALK5 inhibition in myelofibrosis

Por Yue, Lanzhu, Bartenstein, Matthias, Zhao, Wanke, Ho, Wanting Tina, Han, Ying, Murdun, Cem, Mailloux, Adam W., Zhang, Ling, Wang, Xuefeng, Budhathoki, Anjali, Pradhan, Kith, Rapaport, Franck, Wang, Huaquan, Shao, Zonghong, Ren, Xiubao, Steidl, Ulrich, Levine, Ross L., Zhao, Zhizhuang Joe, Verma, Amit, Epling-Burnette, Pearlie K.
Publicado no JCI Insight (2017)